30 July 2018
Visiongain’ has launched a new pharma report 3D Printing for Healthcare World Market Report: Forecasts by Products (Dental Products, Medical Implants, Bio-Printing, Others) By Technology (Hardware, Software, Services) & Analysis of Opportunities in Personalised Medicine, Medical Devices, Tailor Made Prosthetics, Orthopaedic Implants & Drugs
The 3D printing for healthcare market is in an emerging state due to the large number of developments by the leading market players and high adoption rate of 3D printing for healthcare. The key players of the world 3D printing for healthcare market are employing novel concepts and ideas, improving manufacturing techniques, and improving the current set of products, besides enhancing their profitability to gain a competitive edge over other market players. Therefore, key players have adopted acquisition & product launch and development as the key developmental strategies to cater to the changing demands of end users.
The lead analyst of the report commented “The demand for 3D printed products and solutions in healthcare will increase throughout the forecast period. The ability to create patient-specific solutions across a variety of healthcare applications offers a number of advantages in terms of both costs and outcomes for patients, payers and providers. Therefore, implementation of 3D printing technology is being driven by healthcare providers who aim to improve quality of life for their patients whilst minimising costs, and by patients, whose improving knowledge and understanding of their treatment options ensures they demand a more personalised approach.”
Leading companies featured in the report include 3D Systems Inc., Arcam AB, Autodesk Inc., ExOne Company, H Intressenter AB, Optomec, Inc., Organovo Holdings, Inc., Ponoko Limited, Stratasys Ltd, Voxeljet AG
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 208 781 6953
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.
31 January 2023
The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.
31 January 2023
The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.
31 January 2023
The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.